Ichor Holdings, Ltd.

ON Semiconductor Corporation

Upwork Inc.

Credo Technology Group Holding Ltd

Medpace Holdings, Inc.

The Goodyear Tire & Rubber Company

NVIDIA Corporation

Microsoft Corporation

Alphabet Inc.

Valaris Limited

Novo Nordisk A/S

STMicroelectronics N.V.

Workday, Inc.

Micron Technology, Inc.

monday.com Ltd.

Daily review and forecast of events on the U.S. stock market from Mikhail Denislamov, Deputy Director of Freedom Capital Markets Research.

Morning in New York: Statistics and Fed rhetoric will set the tone for trading

SpyGlass Pharma, Inc. Common Stock

Preliminary trading in shares of SpyGlass Pharma has begun on the Freedom customer trading system. This biotech startup is developing a system designed to reduce intraocular pressure in patients with glaucoma and cataracts. Later on February 6, the company's securities will appear on the Nasdaq exchange under the ticker <a href="https://tradernet.global/terminal?ticker=SGP.US">SGP</a>. Click on the <a href="https://tradernet.global/terminal?ticker=SGP.US">SGP</a> ticker to participate.

SpyGlass Pharma IPO: developer of eye disease therapy device goes public

F5, Inc.

ASML Holding N.V.

Texas Instruments Incorporated

Seagate Technology Holdings plc

Venu Holding Corporation

Qorvo, Inc.

General Motors Company

Richtech Robotics Inc.

HCA Healthcare, Inc.

UnitedHealth Group Incorporated

Synchrony Financial

Morning in New York: Fed signals in focus

Eli Lilly and Company

SK hynix Inc.

OpenAI strengthens its presence in medicine, Nvidia and Eli Lilly launch a billion-dollar AI project in pharma, and SK Hynix invests billions of dollars in HBM memory production. These and other topics are covered in our roundup of key events for the morning of January 13.

Highlights for the morning: US duties on Iran's partners, the OpenAI deal and Venezuela's market surge

Taiwan Semiconductor Manufacturing Company Limited

The Boeing Company

Sable Offshore Corp.

Tesla, Inc.

Axsome Therapeutics, Inc.

Ondas Inc.

Corcept Therapeutics Incorporated

Hyatt Hotels Corporation

Daily review and forecast of events on the US stock market by Mikhail Denislavov, Deputy Director of Freedom Capital Markets Research.

Morning in New York: Stock market players capitalize on post-holiday momentum

Sanofi

The corporation is diversifying its sources of growth beyond its key asthma drug Dupixent

Sanofi is expanding its vaccine business. It will buy Dynavax for $2.2 billion

Hanwha Ocean Co., Ltd.

Paramount Skydance Corporation

Warner Bros. Discovery, Inc.

The US Food and Drug Administration (FDA) has approved Novo Nordisk's first semaglutide-based GLP-1 obesity pill, intensifying the company's competition with Eli Lilly. ByteDance, owner of TikTok, plans to invest about $23 billion in AI infrastructure amid record growth in debt financing in the global tech sector. These and other topics - in our review of key events for the morning of December 23.

The main thing for the morning: a pill instead of a shot, ships for the U.S. Navy and $40 billion for Hollywood

Nektar Therapeutics

Pfizer Inc.

AbbVie Inc.

Freedom Broker has issued a short-term investment idea to buy shares of Nektar Therapeutics, a small-cap biotech developing a drug for alopecia areata, an autoimmune condition that causes hair loss. On Tuesday, December 16, the company is set to <a href="https://ir.nektar.com/news-releases/news-release-details/nektar-hold-conference-call-discuss-topline-results-36-week">release</a>&nbsp;new clinical trial data on its lead therapy. If the results are positive, Nektar shares could gain about 22% over the next two months, Freedom Broker analysts said.

Freedom Broker: Nektar may jump 22% in two months on potential upbeat trial results

The Oncology Institute, Inc.

Nutex Health Inc.

Claritev Corporation

Healthcare small caps have gained momentum in 2025. According to a Bloomberg Intelligence report published in November, the top-performing segments of the Russell 2000 in the first quarter of 2025 were utilities first, financials second, and health care third.

These small-cap healthcare names have rocketed YTD

Bank of America reaffirmed its "buy" recommendation for shares of pharmaceutical company Eli Lilly and raised the target forecast for its securities from $950 to $1286, CNBC <a href="https://www.cnbc.com/2025/12/02/bank-of-america-hikes-eli-lilly-price-target-on-promising-drug-pipeline.html">reports</a>. This estimate assumes growth of about 22% from the current figures.

"Confident Leadership. Bank of America expects Eli Lilly shares to grow by more than 20%

Brookfield Renewable Corporation

Norfolk Southern Corporation

They are shifting their focus to health care, manufacturing and materials, which benefit from structural changes in the economy

AI stocks have come under pressure. Which sectors are now favored by managers?

Krispy Kreme, Inc.

Opendoor Technologies Inc.

Beyond Meat, Inc.

Cracker Barrel Old Country Store, Inc.

In October, short sellers ramped up pressure on small- and mid-cap stocks, <i>Barron’s </i><a href="https://www.barrons.com/articles/short-sellers-small-caps-meme-stocks-06a426a1?st=5FGUar">reports</a>. Short interest in these companies rose to 7.5% from 7.3% in September, according to Melissa Roberts, an analyst with Stephens. For megacaps, it edged down to 1.8% from 1.9%. Roberts flagged healthcare small caps and mid-cap consumer-lending names among the most targeted stocks.

Shorts are coming after small- and mid-cap stocks. Which names are feeling pressure?